Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cocrystal Pharma
(8CC.F) Q2 2026
Earnings
8CC.F
May 15
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.45
-0.34
-0.24
-0.13
Details
Expected EPS
-0.1290285
Actual EPS
-0.1462323
Surprise EPS
-0.02
Surprise Percent
-13.33%
Description
Cocrystal Pharma (8CC.F) has reported earnings of -0.1462323 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login